Christopher L McClurkan
Overview
Explore the profile of Christopher L McClurkan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Babu T, Shen X, McClelland R, Wang Z, Selke S, Wilkens C, et al.
Open Forum Infect Dis
. 2024 Feb;
11(2):ofad673.
PMID: 38379566
We evaluated the immunologic response to a novel vaccine regimen that included 2 doses of NVX-CoV2373 (Novavax) followed by 1 dose of BNT162b2 (Pfizer-BioNTech) monovalent booster vaccine. A durable neutralizing...
2.
Ford E, Mayer-Blackwell K, Jing L, Laing K, Sholukh A, St Germain R, et al.
Nat Immunol
. 2023 Dec;
25(1):166-177.
PMID: 38057617
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hybrid immunity is more protective than vaccination or previous infection alone. To investigate the kinetics of spike-reactive T (T) cells from SARS-CoV-2 infection...
3.
Laing K, Ouwendijk W, Campbell V, McClurkan C, Mortazavi S, Waters M, et al.
Nat Commun
. 2022 Nov;
13(1):6957.
PMID: 36376285
Herpes zoster is a localized skin infection caused by reactivation of latent varicella-zoster virus. Tissue-resident T cells likely control skin infections. Zoster provides a unique opportunity to determine if focal...
4.
Ford E, Mayer-Blackwell K, Jing L, Sholukh A, St Germain R, Bossard E, et al.
Res Sq
. 2022 Oct;
PMID: 36263073
Almost three years into the SARS-CoV-2 pandemic, hybrid immunity is highly prevalent worldwide and more protective than vaccination or prior infection alone. Given emerging resistance of variant strains to neutralizing...
5.
Pleyer C, Laing K, Ali M, McClurkan C, Soto S, Ahn I, et al.
Blood Adv
. 2022 Feb;
6(6):1732-1740.
PMID: 35157769
Vaccinations effectively prevent infections; however, patients with chronic lymphocytic leukemia (CLL) have reduced antibody responses following vaccinations. Combined humoral and cellular immune responses to novel adjuvanted vaccines are not well...
6.
Jing L, Wu X, Krist M, Hsiang T, Campbell V, McClurkan C, et al.
JCI Insight
. 2022 Feb;
7(6).
PMID: 35133988
SARS-CoV-2 provokes a robust T cell response. Peptide-based studies exclude antigen processing and presentation biology, which may influence T cell detection studies. To focus on responses to whole virus and...
7.
Jing L, Wu X, Krist M, Hsiang T, Campbell V, McClurkan C, et al.
medRxiv
. 2022 Feb;
PMID: 35118477
SARS-CoV-2 provokes a brisk T cell response. Peptide-based studies exclude antigen processing and presentation biology and may influence T cell detection studies. To focus on responses to whole virus and...
8.
Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro A, et al.
J Clin Invest
. 2020 Dec;
131(3).
PMID: 33320842
BACKGROUNDSARS-CoV-2-specific antibodies may protect from reinfection and disease, providing rationale for administration of plasma containing SARS-CoV-2-neutralizing antibodies (nAbs) as a treatment for COVID-19. Clinical factors and laboratory assays to streamline...
9.
Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro A, et al.
medRxiv
. 2020 Oct;
PMID: 33052361
Background: SARS-CoV-2-specific antibodies may protect from reinfection and disease, providing the rationale for administration of plasma containing SARS-CoV-2 neutralizing antibodies (nAb) as a treatment for COVID-19. The clinical factors and...
10.
Campbell V, Nguyen L, Snoey E, McClurkan C, Laing K, Dong L, et al.
Immunohorizons
. 2020 Aug;
4(8):444-453.
PMID: 32753403
Zika virus (ZIKV) is a mosquito-borne pathogen that caused an epidemic in 2015-2016. ZIKV-specific T cell responses are functional in animal infection models, and helper CD4 T cells promote avid...